N/A Completed N=59 Treatment

Study to Evaluate Satisfaction After Treatment With Kysse

Lip Augmentation

Source: ClinicalTrials.gov NCT03967444 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Mar 2021

Primary outcomePrimary: Assess Treatment With Restylane Kysse Using GAIS — 18; 38 Participants

Summary

Open-label, phase IV, post-marketing study to evaluate aesthetic improvement and satisfaction after treatment with Kysse.

Outcome Measures

Outcome	Result	p-value
PRIMARY Assess Treatment With Restylane Kysse Using GAIS	18; 38	—

Eligibility Criteria

Inclusion Criteria

Signed and dated informed consent to participate in the study
Adult women and men who intend to undergo lip augmentation

Exclusion Criteria

Subjects presenting with known allergy to HA (hyaluronic acid) filler or amide local anesthetics
Subjects with a previous implant other than HA in or near the intended treatment site
Participation in any other clinical study within three (3) months before treatment

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03967444). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.